Bernstein analyst Justin Smith initiated coverage of Sanofi (SNY) with an Outperform rating and EUR 110 price target The firm sees the company’s new CEO unlocking share value.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Trump Trade: President issues short-term waiver of Jones Act
- Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
- District court rules federal limits to vaccines not based on science, NYT says
- Regeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease
- Sanofi Targets Real-World Teplizumab Data in Type 1 Diabetes: What Investors Should Watch